Back

Biomarkers of atrial remodelling and risk of cardiovascular death in patients with hypertension: the LOOP study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Imaging in left ventricular hypertrophy phenotype Tissue Doppler, Speckle Tracking and Strain Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Adam Femerling Langhoff

Herlev and Gentofte Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Fatty liver disease as risk factors for the clinical expression of hypertrophic cardiomyopathy
Doctor Y. Ahn (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Evolution of cardiac damage staged with echocardiography in Fabry disease
Doctor R. Lillo (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis
Doctor D. Koeckerling (Heidelberg, DE)
Abstract Slides Video
Presentation thumbnail
Characterization of left ventricular 2-dimentional strain imaging in carpal tunnel syndrome associated with wild-type transthyretin amyloidosis
Professor T. Tsuruda (Miyazaki, JP)
Abstract Slides Video
Presentation thumbnail
EF/MAPSE ratio: a new echocardiographic parameter for the diagnosis of cardiac amyloidosis
Doctor I. Constantin (Buenos Aires, AR)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging in left ventricular hypertrophy phenotype

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Focus on atrial cardiomyopathy and right ventricular function: what is new?
thumbnail
Congress Session
Echocardiographic imaging in atrial fibrillation and atrial cardiomyopathy
thumbnail
Congress Presentation
Left and right atrial strain predict all-cause mortality and heart failure related hospitalizations in ATTR cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources